Health Care News and Research

RSS

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Symbiomix Therapeutics today announced multiple milestones, including the closing of the third and final tranche of a $41 million Series A financing and positive results from a multi-center, randomized Phase 2 trial testing a single oral dose of SYM-1219 for the treatment of bacterial vaginosis (BV).

6 May 2015

Pacific Lipo surgical center achieves AAAHC accreditation

Pacific Lipo has achieved accreditation and is officially certified by the Accreditation Association for Ambulatory Health Care. "Accreditation distinguishes our surgery center from many other outpatient facilities by providing the highest quality of care to our patients as determined by an independent, external process of evaluation and inspection," says Rodney Davis, Physician Assistant and Liposculpture Specialist at Pacific Lipo.

6 May 2015

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.

6 May 2015

Common electric brain stimulation has significant detrimental effect on IQ scores

Using a weak electric current in an attempt to boost brainpower or treat conditions has become popular among scientists and do-it-yourselfers, but a new University of North Carolina School of Medicine study shows that using the most common form of electric brain stimulation had a statistically significant detrimental effect on IQ scores.

6 May 2015

E-learning can provide efficient approach to training psychotherapists in new evidence-based treatments

Employing online training programs to teach psychotherapists how to use newer evidence-based treatments can be as successful as in-person instruction, according to a new RAND Corporation study.

6 May 2015

Intervention to connect low-income uninsured patients to primary care could improve health, reduce costs

An intervention to connect low-income uninsured and Medicaid patients to a reliable source of primary health care shows promise for reducing avoidable use of hospital emergency departments in Maryland. A University of Maryland School of Public Health study evaluating the results of the intervention was published this week in the May issue of the journal Health Affairs.

6 May 2015

Proteomics helps identify previously unrecognized proteins and pathways in nerve regeneration

Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins--the oncogene c-myc--they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.

5 May 2015

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.

From Lucideon 5 May 2015

AMC Health to collaborate with URAC on national telehealth standards development initiative

AMC Health, a leading provider of 'real-time' patient management solutions has announced that it will collaborate with URAC on its national telehealth standards development initiative.

5 May 2015

Bayer to further develop ISIS-FXIRx antisense investigational drug for thrombosis prevention

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need.

5 May 2015

WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

Worldwide close to 80 million people are currently impacted by humanitarian emergencies arising from natural disasters and armed conflicts, such as those in the Central African Republic, South Sudan, Syrian Arab Republic, Yemen, and more recently, Nepal. WHO estimates 5% to 10% of these people suffer from a mental health condition such as depression as a result of the emergency.

5 May 2015

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of prostate-specific membrane antigen (PSMA) in patients with biochemical recurrence after radical prostatectomy.

5 May 2015

Spirometry underutilized for asthma management in U.S. adults

Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and the publication of national guidelines advocating its use.

5 May 2015

Family, neighborhood environments affect mental health outcomes in children

A team of researchers from Sweden and the United States have examined the potential role of the family environment and neighborhood factors on mental health outcomes in a new study published in Journal of Psychiatric Research.

5 May 2015

IQWiG finds minor added benefit of dulaglutide in combination with short-acting insulin for type 2 diabetes

Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type 2 diabetes. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapies.

5 May 2015

Frederick Alt honored with 2015 Szent-Györgyi Prize for Progress in Cancer Research

Frederick Alt, PhD, director of the Program in Cellular and Molecular Medicine at Boston Children's Hospital, has been honored with the 2015 Szent-Györgyi Prize for Progress in Cancer Research.

4 May 2015

Novation reports dual-contract award in Bone Densitometry category

Novation today announced its dual-contract award in the Bone Densitometry category. Hologic, Inc. and Swissray International Inc. were both awarded agreements, replacing incumbent GE Healthcare in this category.

4 May 2015

Study shows how pharmacies may play important role in reducing asthma-related illness

A new study shows how pharmacies might collaborate with physicians and families to reduce asthma-related illness.

4 May 2015

VHI publishes 20 new hospital quality measures

Virginia Health Information published 20 new hospital quality measures to help Virginians make more informed choices when choosing hospitals. The measures include mortality rates for pneumonia and stroke and results of care such as blood clots and accidental cuts and tears during treatment as well as more than a dozen other measures including many patient safety topics.

30 Apr 2015

St. Luke's Celebrates Groundbreaking for New Hospital in Monroe County

St. Luke’s University Health Network has broken ground for the new St. Luke’s Hospital-Monroe Campus, adjacent to Wigwam Road and Route 611, in Bartonsville. This will be the first new hospital in Monroe County in 100 years.

30 Apr 2015

Health Care News and Research

Symbiomix closes $41 million Series A financing and reports positive results from SYM-1219 Phase 2 trial

Pacific Lipo surgical center achieves AAAHC accreditation

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall

Common electric brain stimulation has significant detrimental effect on IQ scores

E-learning can provide efficient approach to training psychotherapists in new evidence-based treatments

Intervention to connect low-income uninsured patients to primary care could improve health, reduce costs

Proteomics helps identify previously unrecognized proteins and pathways in nerve regeneration

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

AMC Health to collaborate with URAC on national telehealth standards development initiative

Bayer to further develop ISIS-FXIRx antisense investigational drug for thrombosis prevention

WHO and UNHCR jointly issue new guide to better identify, manage mental health needs

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

Spirometry underutilized for asthma management in U.S. adults

Family, neighborhood environments affect mental health outcomes in children

IQWiG finds minor added benefit of dulaglutide in combination with short-acting insulin for type 2 diabetes

Frederick Alt honored with 2015 Szent-Györgyi Prize for Progress in Cancer Research

Novation reports dual-contract award in Bone Densitometry category

Study shows how pharmacies may play important role in reducing asthma-related illness

VHI publishes 20 new hospital quality measures

St. Luke's Celebrates Groundbreaking for New Hospital in Monroe County

Event guide: 3rd Measuring Patient Engagement Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News